Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

623 Articles

Chris Lange | Jun 27, 2017 at 8:45 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jun 12, 2017 at 8:55 AM EDT

Short Sellers Grow More Selective on Major Pharma

The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 2, 2017 at 1:35 PM EDT

15 Companies Bracing for Big ASCO Reactions

24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could…

Chris Lange | May 27, 2017 at 8:40 AM EDT

Big Pharma Has Big Catalysts Coming for the Rest of 2017

A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow…

Chris Lange | May 25, 2017 at 9:45 AM EDT

Major Pharma Short Interest Surges

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 17, 2017 at 12:10 PM EDT

Why This Humira Patent Loss Might Not Be What You Think

AbbVie watched its shares slide on Wednesday following a ruling from the U.S. Patent and Trade Mark Office's Trial and…

Paul Ausick | May 15, 2017 at 11:35 AM EDT

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.

Chris Lange | May 10, 2017 at 9:00 AM EDT

Short Interest in Major Pharma Shrinks

The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Apr 27, 2017 at 8:30 AM EDT

Jefferies Makes a Huge Surprise Addition to Franchise Picks Portfolio

The analysts at Jefferies have made a big move by adding a top consumer goods/auto parts company to the firm's…

Chris Lange | Apr 26, 2017 at 11:30 AM EDT

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their…

Chris Lange | Apr 26, 2017 at 8:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Apr 17, 2017 at 10:00 AM EDT

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and…

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 26 27 28 29 30 … 42

AbbVie : ABBV

All AbbVie Articles

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma

15 Companies Bracing for Big ASCO Reactions

Top Presentations to Look for at ASCO

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

Why This Humira Patent Loss Might Not Be What You Think

Top Credit Suisse Pharma Picks Ahead of Catalysts

Short Interest in Major Pharma Shrinks

Jefferies Makes a Huge Surprise Addition to Franchise Picks Portfolio

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

3 Boring but Brilliant Stocks to Buy in August

XRP Price Prediction: Analyst Says XRP Will Hit $27 by October 2026

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

Social Isolation Can Quietly Wreck a Retiree's Health. Original Medicare Won't Spend a Cent to Prevent It.

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

3 Boring but Brilliant Stocks to Buy in August

AbbVie : ABBV

All AbbVie Articles

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma

15 Companies Bracing for Big ASCO Reactions

Top Presentations to Look for at ASCO

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

Why This Humira Patent Loss Might Not Be What You Think

Top Credit Suisse Pharma Picks Ahead of Catalysts

Short Interest in Major Pharma Shrinks

Jefferies Makes a Huge Surprise Addition to Franchise Picks Portfolio

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

3 Boring but Brilliant Stocks to Buy in August

XRP Price Prediction: Analyst Says XRP Will Hit $27 by October 2026

Featured Reads

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

Social Isolation Can Quietly Wreck a Retiree's Health. Original Medicare Won't Spend a Cent to Prevent It.